
This item is available for pre-order. Your order will be processed and shipped once the product becomes available. You will receive an email notification when your pre-order is ready to ship.
NAD+ is an endogenous pyridine nucleotide that plays a central role in cellular redox reactions and energy metabolism and is widely utilized as a biochemical reagent in laboratory research. In non-human and in vitro models, investigators study NAD+ to examine mitochondrial function, oxidative phosphorylation, DNA repair pathways, and the activity of NAD+-dependent enzymes such as sirtuins and PARPs. Preclinical work has also explored its turnover, compartmentalization, and metabolic regulation under conditions of cellular stress, aging, and metabolic challenge. NextGenPeps supplies NAD+ as a high-purity research compound intended solely for controlled laboratory experimentation, including in vitro systems and approved animal models. This material is not approved as a drug, diagnostic agent, or dietary ingredient and is not intended for human consumption, clinical use, or any application outside properly authorized research settings.
Reliable and innovative research with our top-grade research materials and novel research compounds tailored to lead the competitive research industry. Choose research quality. Choose NextGenPeps.
Sign up now and receive a 10% discount code valid on your next purchase!
NextGenPeps LLC | 1331 Columbia Street, San Diego, CA 92101 | Copyright 2025 NextGenPeps
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All Peptide research products on this site are for research and development use only, and not intended for human use.
NextGenPeps is a chemical supplier. NextGenPeps is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. NextGenPeps is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.